Overview
RELX PLC is a global provider of information and analytics for professional and business customers across industries. Based in the United Kingdom, the company operates in four major sectors: Scientific, Technical & Medical, Risk & Business Analytics, Legal, and Exhibitions. RELX’s history of high-quality content curation stretches over decades, primarily focusing on leveraging technology to deliver data-driven insights that help support scientific, medical, and legal decisions. Key projects often involve large-scale data processing frameworks, development of analytic tools, and strategic acquisitions to broaden its technological capabilities and market reach. This focus solidifies RELX’s reputation as a leader in turning information into actionable knowledge, serving customers in over 180 countries.
Basic Stats
The share price of RELX PLC as of 5 September 2025 is 3,482.00 GBX / share. This is an increase of 1.04% from the prior week. The market cap (or net worth) of RELX PLC as of 5 September 2025 is 63,841.51 GBX MM.
The Factor Analysis chart (below right) shows a view of RELX PLC from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 63,841.51 MM |
| EV | 71,087.51 MM |
| Shares Out. | 1,831.80 MM |
| Earnings Date | |
| EPS (TTM) | 1.05 |
| Dividend Yield | 1.84 % |
| Ex-Dividend Date | 2025-08-07 |
| Borrow Rate | 0.49 |
| Short Shares Avail. | 0.35 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 0.26 % |
| Volatility (1 yr) | 0.20 |
| Beta | 0.75 |
| Sharpe Ratio (1 yr) | -0.20 |
| Sortino Ratio (1 yr) | -0.30 |
| PE Ratio | 33.16 |
| Price/Book | 29.10 |
| Price/TBV | -7.38 |
| Book/Market | 0.03 |
| EBIT/EV | 0.04 |
| EBIT(3yr avg)/EV | 0.03 |
| ROA | 0.13 |
| ROE | 0.60 |
| ROIC | 0.20 |
| CROIC | 0.01 |
| OCROIC | 0.28 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 69.83 /100 |
| Profitability | 82.11 /100 |
| Quality Score | 81.15 /100 |
| Value Score | 56.84 /100 |
| Momentum Score | 21.68 /100 |
| Stability (Low Vol) Score | 88.14 /100 |
| Analyst Sentiment | 81.74 /100 |
| Fund Sentiment | 39.28 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | 47.82 /100 |
| QVM Score | 59.59 /100 |
| Piotroski F-SCORE | 7.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for RELX PLC is 4,575.29 GBX. The forecasts range from a low of 4,040.00 GBX to a high of 5,880.00 GBX. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for RELX PLC. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-19 | Goldman Sachs | Neutral | Downgrade | |
| 2022-11-10 | Barclays | Overweight | Reiterate | |
| 2022-10-24 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2022-10-21 | Credit Suisse | Outperform | Reiterate | |
| 2022-10-21 | Berenberg Bank | Hold | Reiterate | |
| 2022-10-21 | Barclays | Overweight | Reiterate | |
| 2022-10-05 | Deutsche | Hold | Reiterate | |
| 2022-09-27 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2022-09-23 | Berenberg Bank | Hold | Reiterate | |
| 2022-08-31 | Barclays | Overweight | Reiterate | |
| 2022-07-13 | Berenberg Bank | Hold | Reiterate | |
| 2022-07-13 | Barclays | Overweight | Reiterate | |
| 2022-03-09 | Morgan Stanley | Overweight | Reiterate | |
| 2022-02-11 | Berenberg Bank | Hold | Reiterate | |
| 2022-02-11 | Barclays | Overweight | Reiterate | |
| 2022-02-11 | Berenberg Bank | Reiteration | Reiterate | |
| 2022-02-11 | Barclays | Reiteration | Reiterate | |
| 2022-02-09 | Morgan Stanley | Reiteration | Reiterate | |
| 2022-02-08 | Deutsche | Reiteration | Reiterate | |
| 2022-01-28 | Barclays | Reiteration | Reiterate | |
| 2022-01-25 | Deutsche | Reiteration | Reiterate | |
| 2021-12-10 | JP Morgan Cazenove | Reiteration | Reiterate | |
| 2021-11-17 | Berenberg Bank | Reiteration | Reiterate | |
| 2021-10-22 | Barclays | Overweight | Reiterate | |
| 2021-10-19 | Deutsche Bank | Hold | Reiterate | |
| 2021-10-08 | Barclays | Overweight | Reiterate | |
| 2021-07-30 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2021-07-30 | Barclays | Overweight | Reiterate | |
| 2021-07-05 | Citigroup | Reiteration | Reiterate | |
| 2021-06-23 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2020-07-28 | Berenberg Bank | Hold | Reiterate | |
| 2020-06-18 | Credit Suisse | Outperform | Reiterate | |
| 2020-05-11 | Credit Suisse | Outperform | Reiterate | |
| 2020-03-05 | UBS | Sell | Neutral | Upgrade |
| 2020-01-30 | Barclays | Overweight | Reiterate | |
| 2020-01-28 | Morgan Stanley | Equal-weight | Reiterate | |
| 2020-01-21 | Citigroup | Neutral | Buy | Upgrade |
| 2020-01-14 | Berenberg Bank | Buy | Reiterate | |
| 2019-10-25 | Barclays | Overweight | Reiterate | |
| 2019-10-24 | Liberum Capital | Buy | Reiterate | |
| 2019-10-24 | Berenberg Bank | Buy | Reiterate | |
| 2019-09-16 | UBS | Sell | Reiterate | |
| 2019-08-14 | Citigroup | Neutral | Reiterate | |
| 2019-03-04 | Berenberg Bank | Buy | Reiterate | |
| 2019-02-21 | Numis | Hold | Reiterate | |
| 2019-01-25 | Societe Generale | Buy | Reiterate | |
| 2018-10-25 | UBS | Sell | Reiterate | |
| 2018-10-24 | Liberum Capital | Buy | Reiterate | |
| 2018-10-05 | Berenberg Bank | Buy | Reiterate | |
| 2018-09-24 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2018-09-18 | UBS | Sell | Reiterate | |
| 2018-07-27 | Deutsche Bank | Buy | Reiterate | |
| 2018-07-12 | Deutsche Bank | Buy | Reiterate | |
| 2018-05-18 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2018-02-26 | Citigroup | Neutral | Reiterate | |
| 2018-02-12 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2018-02-09 | Deutsche Bank | Hold | Buy | Upgrade |
| 2018-01-10 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2017-07-28 | Macquarie | Underperform | Reiterate | |
| 2017-07-28 | Deutsche Bank | Hold | Reiterate | |
| 2017-07-28 | Barclays | Overweight | Reiterate | |
| 2017-07-27 | Numis Securities | Hold | Reiterate | |
| 2017-07-07 | Barclays | Overweight | Reiterate | |
| 2017-03-03 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2017-02-28 | Berenberg Bank | Buy | Reiterate | |
| 2017-02-24 | Deutsche Bank | Hold | Reiterate | |
| 2017-02-24 | Barclays | Overweight | Reiterate | |
| 2017-02-23 | Numis Securities | Hold | Reiterate | |
| 2017-02-20 | UBS | Buy | Reiterate | |
| 2017-02-16 | Deutsche Bank | Hold | Reiterate | |
| 2017-01-26 | Macquarie | Underperform | Reiterate | |
| 2017-01-16 | Exane BNP Paribas | Outperform | Reiterate | |
| 2017-01-05 | Investec | Buy | Reiterate | |
| 2016-11-22 | Credit Suisse | Outperform | Reiterate | |
| 2016-11-15 | UBS | Buy | Reiterate | |
| 2016-11-11 | Deutsche Bank | Hold | Reiterate | |
| 2016-10-20 | Exane BNP Paribas | Outperform | Reiterate | |
| 2016-09-22 | Exane BNP Paribas | Outperform | Reiterate | |
| 2016-09-14 | Berenberg Bank | Buy | Reiterate | |
| 2016-09-13 | UBS | Buy | Reiterate | |
| 2016-08-18 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2016-08-09 | Credit Suisse | Neutral | Reiterate | |
| 2016-08-08 | Goldman Sachs | Neutral | Reiterate | |
| 2016-07-29 | Deutsche Bank | Hold | Reiterate | |
| 2016-07-29 | Barclays | Overweight | Reiterate | |
| 2016-07-19 | Goldman Sachs | Neutral | Reiterate | |
| 2016-07-15 | UBS | Buy | Reiterate | |
| 2016-07-04 | Barclays | Overweight | Reiterate | |
| 2016-06-27 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2016-05-03 | Goldman Sachs | Buy | Hold | Downgrade |
| 2016-04-19 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2016-04-19 | Barclays | Overweight | Reiterate | |
| 2016-04-06 | Berenberg Bank | Buy | Reiterate | |
| 2016-03-24 | Nomura | Buy | Reiterate | |
| 2016-03-24 | Credit Suisse | Neutral | Reiterate | |
| 2016-02-26 | Societe Generale | Buy | Reiterate | |
| 2016-02-26 | Nomura | Buy | Reiterate | |
| 2016-02-26 | Exane BNP Paribas | Outperform | Reiterate | |
| 2016-02-25 | Investec | Buy | Reiterate | |
| 2016-02-01 | Deutsche Bank | Buy | Reiterate | |
| 2016-01-28 | Barclays | Overweight | Reiterate | |
| 2016-01-20 | Goldman Sachs | Buy | Reiterate | |
| 2016-01-19 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2015-11-20 | Nomura | Buy | Reiterate | |
| 2015-11-20 | Investec | Buy | Reiterate | |
| 2015-11-10 | Societe Generale | Buy | Reiterate | |
| 2015-11-03 | Macquarie | Underperform | Neutral | Upgrade |
| 2015-11-02 | Macquarie | Underperform | Neutral | Upgrade |
| 2015-10-23 | Nomura | Buy | Reiterate | |
| 2015-10-23 | Exane BNP Paribas | Outperform | Reiterate | |
| 2015-10-14 | Investec | Buy | Reiterate | |
| 2015-10-07 | Jefferies | Hold | Reiterate | |
| 2015-10-07 | Deutsche Bank | Buy | Upgrade | |
| 2015-09-03 | Credit Suisse | Neutral | Reiterate | |
| 2015-07-24 | Societe Generale | Buy | Reiterate | |
| 2015-07-24 | Nomura | Buy | Reiterate | |
| 2015-07-24 | Barclays | Overweight | Reiterate | |
| 2015-07-23 | Numis | Add | Reiterate | |
| 2015-07-17 | Goldman Sachs | Buy | Reiterate | |
| 2015-06-03 | Investec | Buy | Reiterate | |
| 2015-05-19 | Nomura | Buy | Reiterate | |
| 2015-04-20 | Bank of America | Neutral | Downgrade | |
| 2015-04-13 | Jefferies | Hold | Reiterate | |
| 2015-04-10 | Exane BNP Paribas | Underperform | Reiterate | |
| 2015-04-10 | Credit Suisse | Neutral | Reiterate | |
| 2015-03-12 | Berenberg Bank | Hold | Reiterate | |
| 2015-03-04 | Charles Stanley | Accumulate | Reiterate | |
| 2015-02-27 | Panmure Gordon | Hold | Reiterate | |
| 2015-02-26 | Numis Securities | Add | Reiterate | |
| 2015-01-14 | Goldman Sachs | Neutral | Reiterate | |
| 2015-01-13 | Liberum Capital | Buy | Reiterate | |
| 2015-01-13 | Investec | Buy | Reiterate | |
| 2015-01-12 | Berenberg Bank | Hold | Reiterate | |
| 2014-12-03 | Barclays | Equal-weight | Reiterate | |
| 2014-12-01 | Nomura | Buy | Reiterate | |
| 2014-11-25 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2014-10-24 | Credit Suisse | Neutral | Reiterate | |
| 2014-10-24 | Berenberg Bank | Hold | Reiterate | |
| 2014-10-24 | Barclays | Equal-weight | Reiterate | |
| 2014-10-23 | Numis Securities | Add | Reiterate | |
| 2014-10-23 | Investec | Buy | Reiterate | |
| 2014-10-22 | Liberum Capital | Buy | Reiterate | |
| 2014-09-03 | Credit Suisse | Neutral | Reiterate | |
| 2014-08-15 | Credit Suisse | Neutral | Reiterate | |
| 2014-07-30 | Berenberg Bank | Hold | Reiterate | |
| 2014-07-25 | Societe Generale | Buy | Reiterate | |
| 2014-07-25 | Numis Securities | Add | Reiterate | |
| 2014-07-25 | Nomura | Buy | Reiterate | |
| 2014-07-25 | Morgan Stanley | Overweight | Reiterate | |
| 2014-07-25 | Credit Suisse | Neutral | Reiterate | |
| 2014-07-24 | Numis Securities | Add | Reiterate | |
| 2014-07-24 | Investec | Buy | Reiterate | |
| 2014-07-16 | Numis Securities | Add | Reiterate | |
| 2014-07-14 | Investec | Buy | Reiterate | |
| 2014-07-02 | Credit Suisse | Neutral | Reiterate | |
| 2014-06-27 | Barclays | Equal-weight | Downgrade | |
| 2014-06-12 | Goldman Sachs | Neutral | Reiterate | |
| 2014-06-04 | Nomura | Buy | Reiterate | |
| 2014-04-24 | Citigroup | Buy | Reiterate | |
| 2014-04-23 | Numis Securities | Add | Reiterate | |
| 2014-04-23 | Investec | Buy | Reiterate | |
| 2014-03-17 | Berenberg Bank | Hold | Downgrade | |
| 2014-03-14 | Nomura | Buy | Reiterate | |
| 2014-03-11 | Investec | Buy | Reiterate | |
| 2014-03-03 | Credit Suisse | Neutral | Reiterate | |
| 2014-02-28 | Numis Securities | Add | Reiterate | |
| 2014-02-28 | Nomura | Buy | Reiterate | |
| 2014-02-28 | Deutsche Bank | Buy | Reiterate | |
| 2014-02-28 | Barclays | Overweight | Reiterate | |
| 2014-02-27 | Jefferies | Hold | Reiterate | |
| 2014-02-27 | Investec | Buy | Reiterate | |
| 2014-02-21 | UBS | Neutral | Reiterate | |
| 2014-02-21 | Liberum Capital | Buy | Reiterate | |
| 2014-02-20 | Numis Securities | Add | Reiterate | |
| 2014-02-11 | Deutsche Bank | Buy | Reiterate | |
| 2014-02-07 | Exane BNP Paribas | Neutral | Reiterate | |
| 2014-01-27 | Citigroup | Buy | Reiterate | |
| 2013-12-18 | Investec | Buy | Reiterate | |
| 2013-12-10 | Deutsche Bank | Buy | Reiterate | |
| 2013-12-04 | Nomura | Buy | Reiterate | |
| 2013-11-08 | Societe Generale | Buy | Reiterate | |
| 2013-11-08 | Deutsche Bank | Buy | Reiterate | |
| 2013-11-08 | Credit Suisse | Neutral | Reiterate | |
| 2013-11-07 | Jefferies | Hold | Reiterate | |
| 2013-11-07 | Investec | Buy | Reiterate | |
| 2013-11-05 | Goldman Sachs | Neutral | Reiterate | |
| 2013-10-30 | Exane BNP Paribas | Outperform | Reiterate | |
| 2013-10-21 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2013-10-21 | Deutsche Bank | Buy | Reiterate | |
| 2013-10-18 | Numis Securities | Add | Reiterate | |
| 2013-10-18 | Investec | Buy | Reiterate | |
| 2013-10-16 | Societe Generale | Buy | Reiterate | |
| 2013-10-10 | UBS | Neutral | Reiterate | |
| 2013-09-19 | Barclays | Overweight | Reiterate | |
| 2013-09-12 | Jefferies | Hold | Reiterate | |
| 2013-09-09 | Citigroup | Buy | Upgrade | |
| 2013-07-25 | Numis Securities | Add | Reiterate | |
| 2013-07-25 | Investec | Buy | Reiterate | |
| 2013-07-23 | Nomura | Buy | Reiterate | |
| 2013-07-09 | Nomura | Buy | Reiterate | |
| 2013-07-09 | Investec | Buy | Reiterate | |
| 2013-07-09 | Exane BNP Paribas | Outperform | Reiterate | |
| 2013-07-04 | Espirito Santo Securities | Sell | Reiterate | |
| 2013-07-04 | Deutsche Bank | Buy | Reiterate | |
| 2013-06-27 | Bank of America | Underperform | Reiterate | |
| 2023-01-31 | Barclays | Equal Weight | Downgrade | |
| 2023-02-16 | Numis | Hold | Reiterate | |
| 2023-03-15 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2023-06-13 | Barclays | Equal Weight | Reiterate | |
| 2023-10-03 | Barclays | Equal Weight | Reiterate | |
| 2023-07-03 | Barclays | Equal Weight | Reiterate | |
| 2023-09-13 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2023-09-08 | Barclays | Equal Weight | Reiterate | |
| 2023-11-10 | Berenberg Bank | Buy | Reiterate | |
| 2023-09-27 | Berenberg Bank | Buy | Initiate | |
| 2024-02-16 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2024-01-05 | Berenberg Bank | Buy | Reiterate | |
| 2024-07-04 | Citigroup | Neutral | Reiterate | |
| 2025-07-11 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2025-07-25 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2024-12-05 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2025-01-07 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2025-02-18 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2025-07-25 | Deutsche | Hold | Reiterate |
